Immune shot aims to halt oral cancer before it starts
Prevention
Recruiting now
This study tests whether an injected immune therapy called RP2 can safely treat high-risk oral precancerous spots and prevent them from turning into oral cancer. About 25 adults with certain high-risk mouth conditions will receive the drug directly into the precancerous area. The…
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Prevention
Last updated May 02, 2026 16:18 UTC